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ABSTRACT 
 
The onset and progression of immune-mediated 
inflammatory arthritis, such as rheumatoid arthritis and 
spondyloarthritis, are linked to the IL23-IL17 immune axis, 
so that many therapeutic strategies aim at modulating this 
pathway. However, there is so far no possibility of an in vivo 
direct monitoring, without a biopsy, of the specific T cells 
involved in this modulation. Synovial perfusion, and thus 
synovial angiogenesis, has been recognized as a sensitive and 
early marker of inflammation that can be evaluated via 
quantitative analysis of contrast-enhanced ultrasound 
imaging data. 
We propose a quantitative analysis of contrast enhanced 
ultrasound data, exploiting both a pixel-wise analysis for 
characterizing the perfusion patterns and their heterogeneity 
within a patient’s synovia, and a model that add to the 
gamma-variate function a term accounting for a possible 
slow-flow component, whose presence and amplitude is 
estimated via a variational Bayesian method. 
We show that this quantification allows to find a 
relationship between perfusion parameters to CD4+ T helper 
cells subtypes that are believed to be involved in the IL23-
IL17 immune axis modulation: significant correlations are as 
high as 0.90, suggesting the possibility of estimating T cells 
concentration from non-invasive imaging data.  
     
Index Terms— Quantification, perfusion, contrast 
enhanced ultrasound, arthritis, synovitis, T helper cells, 
variational Bayes, single compartment recirculation 
 
1. INTRODUCTION 
 
The IL23-IL17 immune axis is thought to play a critical role, 
albeit not yet completely understood, in immune-mediated 
inflammatory arthritis, such as rheumatoid arthritis and 
spondyloarthritis. As a result, in the last 10 years drug 
research has focused on developing several therapeutic 
applications to modulate this pathway, aiming at preventing 
progression of chronic disease or providing its stable 
remission [1-3]. However, there is so far no possibility of an 
in vivo direct monitoring of the cytokines involved in this 
immune pathway, without a biopsy. A valuable alternative, 
not yet investigated, might be linking the cytokines 
expression levels with the noninvasive markers of 
inflammation, commonly used in clinics, which correlate 
with arthritis activity. 
In particular, synovial perfusion, and thus synovial 
angiogenesis, has been recognized as a sensitive and early 
marker of inflammation that can be evaluated via quantitative 
analysis of contrast-enhanced ultrasound imaging data [4-5].   
Contrast Enhanced Ultrasound (CEUS) is an imaging 
technique for the visualization and assessment of tissue 
vascularization and perfusion, using microbubbles as contrast 
agent. CEUS has been widely studied for the early detection 
and grading of arthritis diseases, since it allows a non-
invasive assessment of the synovial neo-vascularization and 
of the variations in local perfusion [7-10]. In a previous work, 
we have tackled the CEUS quantification problem at the pixel 
level and we have demonstrated that pixel-wise 
quantification allows such an effective characterization of 
different perfusion patterns that they can be then used to 
discriminate between arthritis subtypes [11]. 
Here, we study the possibility of using a quantitative 
analysis of synovial perfusion parameters as in vivo markers 
of the modulation of immune-mediated inflammation. 
Differently from previous findings [6-7], the identified 
relationships such as to promise that these parameters can be 
used to estimate non-invasively the expression of specific T 
helper (Th17) phenotypes involved in the IL23-IL17 immune 
pathway.        
Although the mechanism linking cytokine expression to 
synovial angiogenesis (and thus synovial perfusion) are 
mostly unknown, the non-invasive quantification of 
perfusion patterns and their heterogeneity paves the way for 
the study of this missing link. 
 
2. MATERIALS 
 
Eight consecutive patients who fulfilled the Classification of 
Psoriatic Arthritis (CASPAR) criteria were enrolled in this 
study. The patients underwent a contrast-enhanced 
ultrasound examination of the most inflamed knee and 
synovial fluid samples were obtained from patients with 
active knee arthritis and synovial fluid effusion. 
The study was approved by the local Ethic Committee of 
the University Hospital of Padova (Italy) (number 52723; 
October 11, 2010), and written informed consent was 
obtained from each participant in accordance with the 
principles outlined in the Declaration of Helsinki, after being 
informed about the intent and the methodology of the study. 
Synovial fluid samples were collected from the swollen 
knees. After centrifugation, the synovial fluid mononuclear 
cells were isolated, plated and incubated and immunostained. 
Mononuclear cells were treated with commercially available 
anti-CD4 antibodies. CD4+ T cells were gated with two 
different approaches: physical characteristic of cells and 
expression of CD4 in the area of lymphocytes. FACS analysis 
was assessed as previously described to identify different 
CD4+ T cells subtypes, that are linked to IL23-IL17 immune 
axis: CD4+, CD4+IL23+, CD4+IL17A-F+, CD4+IL17A-
F+IL23+. 
 
3. METHODS 
 
Ultrasound imaging 
Each subject underwent a 2-min CEUS study with a 7-MHz 
transducer US device (MyLab25, EsaOte, pixel size 0.6 mm, 
dynamic range between 45 and 63 dB, gain between 0 and 20 
dB) equipped with Contrast tuned Imaging (CnTI; Esaote), 
after a bolus injection of 4.8 ml of sulfur hexafluoride-filled 
microbubbles contrast agent (SonoVue, Bracco International 
B.V., Netherlands). Gray-scale US (anatomical B-mode 
image) was acquired before the bolus to define the boundaries 
of the synovial tissue).  
CEUS images were motion corrected and coregistered to 
the anatomical image as described in [11]. We also linearized 
the log-compressed data as in [12] and normalized each pixel 
curve by the maximum value in the image data, in order to 
have the data in the range [0; 1]. 
From the synovial boundaries, we derived an image mask 
that was then modified to include only pixels that showed a 
significant enhancement, considered as the difference 
between baseline value and peak value larger than a fixed 
threshold, set to 0.2 (20% of the data maximum value) based 
on previous studies. 
 
Perfusion model 
CEUS data are generally quantified at the region of interest 
(ROI) level, i.e. analyzing the time intensity curve (TIC) 
obtained by averaging all pixel TICs within a specific user-
defined region. Pixel-wise quantification coupled with a 
physiologically motivated perfusion curve, such as the 
Gamma-variate model, can accurately quantify synovial 
perfusion and it is more flexible and rich than a mono-
exponential or logarithmic model (generally employed for 
CEUS kinetic description [13]) to describe many 
heterogeneous patterns [11]. 
However, the heterogeneity of the CEUS kinetics can be 
such that even a Gamma-variate model does not properly 
describe the time courses. One possible source of this 
 
 
Fig. 1 Representative perfusion model (red solid curve) as 
combination of a gamma-variate component 𝑐𝑔𝑎𝑚𝑚𝑎(𝑝, 𝑡) (dashed 
blue curve) and an apparent trapping component 𝑐𝑆𝐶𝑅(𝑝, 𝑡) (dash-
dot orange curve). 
 
heterogeneity, generally ignored in CEUS data modeling, can 
be an apparent trapping of the microbubbles in newly formed 
vasculature, when characterized by high tortuosity [14]. This 
apparent trapping can also be explained by the limited 
temporal duration of the CEUS scan, that prevents the 
identification of a very slow washout from the data. We thus 
propose the use of a nested model for describing the 
perfusion, the single compartment recirculation model 
[15,16], where the original Gamma-variate was augmented 
with its integral to explicitly model the recirculation of the 
contrast agent. Under the assumption of additive noise, the 
vector of CEUS measurements 𝒄𝒑𝒊𝒙𝒆𝒍(𝑡) is described by: 
 
𝒄𝒑𝒊𝒙𝒆𝒍(𝑡) = 𝐺(𝒑, 𝑡) + 𝒆(𝑡) 
 
where 𝐺(𝒑, 𝑡) is the model with the parameter vector 𝒑 
(which represents all the individual rate constants of the 
model) and 𝒆(𝑡) is the measurement error. The nested SCR 
model is: 
𝑐𝑔𝑎𝑚𝑚𝑎(𝒑, 𝑡) =  
𝑎0
𝑐𝑔𝑎𝑚𝑚𝑎𝑚𝑎𝑥
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𝐺(𝒑, 𝑡) = 𝑐𝑔𝑎𝑚𝑚𝑎(𝒑, 𝑡) + 𝑐𝑆𝐶𝑅(𝒑, 𝑡) 
 
being 𝒑 =[𝑎0, 𝛼, 𝑡0 , 𝛽, 𝑎1] the parameter vector, where 𝑎0 is 
a scaling factor, 𝛼 and 𝛽 determine the bolus shape (raise and 
washout of the dye from the vascular bed),  𝑡0 is the contrast 
arrival time and 𝑎1 is the scaling factor of the trapping 
component. From the set of estimated parameters ?̂? =
[?̂?0, ?̂?, ?̂?0, ?̂?, ?̂?1] ] it is possible to derive a set of additional 
macroparameters, such as the peak value 𝐺𝑚𝑎𝑥, the time of 
peak 𝑡𝑚𝑎𝑥, the raise time 𝑡𝑟𝑎𝑖𝑠𝑒  and the washout time 𝑡𝑤𝑎𝑠ℎ 
(computed as the time needed to raise the intensity from the 
baseline value to half maximum and from the peak value to 
half maximum respectively), the mean transit time 𝑀𝑇𝑇, the 
blood flow index 𝐵𝐹𝐼 and the blood volume index 𝐵𝑉𝐼, for a 
total of 11 parameters for each curve. 
 
Parameter estimation 
The model is identified separately for each pixel using a 
Variational Bayesian (VB) estimator, as proposed in [17], 
which minimizes the difference between the posterior 
distribution of the parameters given the data and the model 
and its (computationally tractable) approximation. 
We also incorporated the Automatic Relevance 
Determination (ARD) [18,19] within the algorithm to allow 
for the automated reduction of model complexity (from SCR 
to Gamma-variate model). This was achieved by using a 
shrinkage prior for the parameter to be subjected to ARD, that 
in our case was the amplitude 𝑎1 of the irreversible 
component. The prior distribution for 𝑎1 was Gaussian with 
zero mean and unknown variance (set initially very large, i.e. 
106) with a Gamma hyper-prior on the variance of 𝑎1 to be 
estimated from the data. The ARD variance becomes very 
small if the data does not support the extra complexity 
introduced by this parameter, so that the 𝑎1 is set to zero as 
the model collapses to the simple Gamma-variate: a 
representative map of the model complexity (𝑎1 equal or 
different from zero) is shown in Fig. 3. 
 
Parameter summarization 
In order to describe the heterogeneity of distinct synovial 
flows as well as the presence of small areas of characteristic 
flow patterns of physiopathology significance, the 
distribution of each parameter over all pixels is summarized 
by four statistical descriptors: mean, standard deviation, 25th 
percentile and 75th percentile. This allows us to explore the 
importance of both the global perfusion patterns in the 
synovia and their variability. In particular, the distribution 
percentiles return information on the areas of the synovia 
characterized by the lowest or highest values of the 
parameters of interest, that can be important in case of 
localized foci of inflammation (Fig. 4). 
 
 
Fig. 2 Parametric map showing the model heterogeneity within a 
patient’s synovium. In yellow the pixels where the automatic 
relevance determination (ARD) procedure estimated the presence of 
the Gamma component alone, and in orange the pixels where ARD 
estimate. 
 
 
Fig. 3 Parametric map of the time-to-peak 𝑡𝑚𝑎𝑥 (a) and of the blood 
volume index (b). From the maps and the correspondent distribution 
(c-d) it is clear that it is not always possible characterize an entire 
synovia by its mean value.  
 
Statistical analysis 
To verify the relationship between the non-invasive imaging 
perfusion patterns and the local levels in the synovia of Th17 
cells, we evaluated the Spearman’s correlation coefficient ρ 
between the parameters derived from the quantitative 
analysis of CEUS data and the expression levels of CD4+, 
CD4+IL23+, CD4+IL17A-F+, CD4+IL17A-F+IL23+. In order 
to accommodate for the scarcity of data, p-values of the 
correlations were computed using permutation test [20]. 
Correlations were considered statistically significant when 
the associated p-values were lower than 5% (p<0.05). 
 
4. RESULTS 
 
We found that the local expression levels of 3 different T cell 
lineages were significantly correlated with imaging perfusion 
estimates (𝜌 ranging from -0.9 and 0.81, p-value<0.05) 
(Table 1). In particular, the variability (as standard deviation) 
of the time of the maximum value reached through the scan, 
the contrast rate of appearance and the blood volume index 
were the most correlated with CD4+ expression (p<0.01). The 
average value in the synovia of the mean transit time was 
interestingly highly correlated with the CD4+ expression (𝜌 = 
0.81, p<0.05) and its 25th percentile was inversely correlated 
with the CD4+ IL17+ IL23+  levels (𝜌 = -0.85, p<0.01). The 
blood volume index was the only parameter correlated with 
all the cell lineages linked to the perfusion parameters. CD4+ 
IL23+ levels were not correlated with any CEUS estimates, 
probably due to the small values of the cell frequencies with 
respect to the IL17+ subtype. In general, considering the 
variability of the perfusion imaging estimates led to higher 
correlations compared to the simple average descriptor, 
highlighting the importance of a pixel-based approach where 
the full physiological description within the area of interest 
can be obtained. 
 
   
CD4+ 
CD4+  
IL17 + 
CD4+  
IL23+ 
CD4+  
IL17+  
IL23+ 
 
𝑡 𝑚
𝑎
𝑥
 
Mean     
 Std Dev -0.90*    
 25 prct     
 75 prct     
 
𝑝
𝑒𝑎
𝑘
 Mean     
 Std Dev     
 
25 prct     
 
75 prct    0.74 
 
𝑡 𝑟
𝑎
𝑖𝑠
𝑒
 Mean     
 Std Dev -0.86*    
 25 prct     
 75 prct -0.75    
 
M
T
T
 Mean 0.81     
 Std Dev     
 
25 prct    -0.85* 
 
75 prct     
 
B
V
I 
 Mean  0.71   
 Std Dev -0.83*    
 25 prct     
 75 prct  0.76  0.80 
 
a 1
/a
0
 Mean     
 Std Dev     
 25 prct    -0.74 
 75 prct     
Tab. 1 Results on a selected set of perfusion parameters computed 
from the model fit. Only statistically significant correlations are 
reported (p<0.05, * for p<0.01). 
 
5. CONCLUSIONS 
 
We showed that the quantitative analysis of a non-invasive 
CEUS imaging scan can be used to determine the presence 
and the extent of local inflammation, that could be identified 
alternatively only with invasive biopsy (measuring Th17 
expression levels). 
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